Fig. 7From: RETRACTED ARTICLE: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancerA schematic diagram of exosomal miR-128-3p based signaling pathway in CRC treatment. In oxaliplatin-resistant CRC cells, exosomal miR-128-3p derived from FHC-128 cells reverse oxaliplatin resistance by competitively binding Bmi1 and MRP5, leading to the increased expression of E-cadherin (suppress EMT phenotype) and reduced the oxaliplatin effluxBack to article page